Scientists aim to predict dangerous drug allergies in childhood leukemia
NCT ID NCT07529223
First seen Apr 30, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study looks at why some people with acute lymphoblastic leukemia (ALL) have severe allergic reactions to the chemotherapy drug asparaginase. Researchers will collect blood samples from 20 patients and test their immune cells in the lab to see if certain T cells become overactive. The goal is to create a test that can predict who is at risk, so treatment can be made safer and more personalized.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHM
Marseille, 13354, France
Contact Email: •••••@•••••
-
CHU de Nice
Nice, CHU de Nice, 06003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.